Search by Drug Name or NDC

    NDC 51754-1008-03 ELCYS 50 mg/mL Details

    ELCYS 50 mg/mL

    ELCYS is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Exela Pharma Sciences, LLC. The primary component is CYSTEINE HYDROCHLORIDE.

    Product Information

    NDC 51754-1008
    Product ID 51754-1008_9a52ae2f-1cea-4ad5-a074-66bbf06578d3
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name ELCYS
    Proprietary Name Suffix n/a
    Non-Proprietary Name Cysteine Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 50
    Active Ingredient Units mg/mL
    Substance Name CYSTEINE HYDROCHLORIDE
    Labeler Name Exela Pharma Sciences, LLC
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA210660
    Listing Certified Through 2024-12-31

    Package

    NDC 51754-1008-03 (51754100803)

    NDC Package Code 51754-1008-3
    Billing NDC 51754100803
    Package 10 CARTON in 1 CASE (51754-1008-3) / 1 VIAL in 1 CARTON (51754-1008-1) / 50 mL in 1 VIAL
    Marketing Start Date 2023-12-12
    NDC Exclude Flag N
    Pricing Information N/A